PITRM1
Presequence protease, mitochondrial
Also known as: hMP1, KIAA1104, MP1, PreP, PREP_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5JRX3
- Gene
- PITRM1
- Ensembl
- ENSG00000107959
- Chromosome
- 10
- Canonical length
- 1037 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Mitochondria
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is an ATP-dependent metalloprotease that degrades post-cleavage mitochondrial transit peptides. The encoded protein binds zinc and can also degrade amyloid beta A4 protein, suggesting a possible role in Alzheimer's disease. [provided by RefSeq, Dec 2016]
Canonical amino-acid sequenceUniProt
1037 residues, UniProt reviewed canonical sequence.
>Q5JRX3|PITRM1
1 MWRCGGRQGL CVLRRLSGGH AHHRAWRWNS NRACERALQY KLGDKIHGFT VNQVTSVPEL
61 FLTAVKLTHD DTGARYLHLA REDTNNLFSV QFRTTPMDST GVPHILEHTV LCGSQKYPCR
121 DPFFKMLNRS LSTFMNAFTA SDYTLYPFST QNPKDFQNLL SVYLDATFFP CLRELDFWQE
181 GWRLEHENPS DPQTPLVFKG VVFNEMKGAF TDNERIFSQH LQNRLLPDHT YSVVSGGDPL
241 CIPELTWEQL KQFHATHYHP SNARFFTYGN FPLEQHLKQI HEEALSKFQK IEPSTVVPAQ
301 TPWDKPREFQ ITCGPDSFAT DPSKQTTISV SFLLPDITDT FEAFTLSLLS SLLTSGPNSP
361 FYKALIESGL GTDFSPDVGY NGYTREAYFS VGLQGIAEKD IETVRSLIDR TIDEVVEKGF
421 EDDRIEALLH KIEIQMKHQS TSFGLMLTSY IASCWNHDGD PVELLKLGNQ LAKFRQCLQE
481 NPKFLQEKVK QYFKNNQHKL TLSMRPDDKY HEKQAQVEAT KLKQKVEALS PGDRQQIYEK
541 GLELRSQQSK PQDASCLPAL KVSDIEPTIP VTELDVVLTA GDIPVQYCAQ PTNGMVYFRA
601 FSSLNTLPEE LRPYVPLFCS VLTKLGCGLL DYREQAQQIE LKTGGMSASP HVLPDDSHMD
661 TYEQGVLFSS LCLDRNLPDM MQLWSEIFNN PCFEEEEHFK VLVKMTAQEL ANGIPDSGHL
721 YASIRAGRTL TPAGDLQETF SGMDQVRLMK RIAEMTDIKP ILRKLPRIKK HLLNGDNMRC
781 SVNATPQQMP QTEKAVEDFL RSIGRSKKER RPVRPHTVEK PVPSSSGGDA HVPHGSQVIR
841 KLVMEPTFKP WQMKTHFLMP FPVNYVGECI RTVPYTDPDH ASLKILARLM TAKFLHTEIR
901 EKGGAYGGGA KLSHNGIFTL YSYRDPNTIE TLQSFGKAVD WAKSGKFTQQ DIDEAKLSVF
961 STVDAPVAPS DKGMDHFLYG LSDEMKQAHR EQLFAVSHDK LLAVSDRYLG TGKSTHGLAI
1021 LGPENPKIAK DPSWIIQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PITRM1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.21
- Highest tissue expression
- 68 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 68 nTPM
- tongue: 56 nTPM
- retina: 46 nTPM
- adrenal gland: 43 nTPM
- heart muscle: 41 nTPM
- thymus: 40 nTPM
Single-cell type
- early spermatids: 217 nCPM
- late spermatids: 131 nCPM
- late primary spermatocytes: 89 nCPM
- oocytes: 78 nCPM
- alveolar cells type 1: 78 nCPM
- pituicytes/fscs: 66 nCPM
Immune cell
- NK-cell: 14 nTPM
- myeloid DC: 13 nTPM
- T-reg: 13 nTPM
- non-classical monocyte: 13 nTPM
- naive CD8 T-cell: 11 nTPM
- memory CD8 T-cell: 11 nTPM
Brain region
- cerebral cortex: 49 nTPM
- white matter: 44 nTPM
- midbrain: 42 nTPM
- pons: 42 nTPM
- thalamus: 41 nTPM
- medulla oblongata: 39 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PITRM1.
Disease | AllUniProt
Conditions PITRM1 is implicated in, by any mechanism.
- Spinocerebellar ataxia, autosomal recessive, 30 (SCAR30) MIM:619405
Disease | GeneticClinVar
4 pathogenic / likely-pathogenic of 502 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Spinocerebellar ataxia, autosomal recessive 30
- Infantile onset spinocerebellar ataxia
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.94
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.84
- DepMap mean gene effect
- -0.27
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Peptidase M16, C-terminal
- Metalloenzyme, LuxS/M16 peptidase-like
- Peptidase M16, N-terminal
- Insulinase (Peptidase family M16)
- Peptidase M16 inactive domain
- Peptidase M16C associated
- Presequence protease, mitochondrial-type, C-terminal domain
- Peptidase M16C associated
- PreP C-terminal domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PITRM1 as an antibody target. Whether an autoantibody or antibody against PITRM1 could matter depends on whether native PITRM1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PITRM1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PITRM1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...